Your browser doesn't support javascript.
loading
Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period.
Fomina, Daria S; Lebedkina, Marina S; Iliukhina, Anna A; Kovyrshina, Anna V; Shelkov, Artem Y; Andreev, Sergey S; Chernov, Anton A; Dolzhikova, Inna V; Kruglova, Tatyana S; Andrenova, Gerelma V; Tukhvatulin, Amir I; Shcheblyakov, Dmitry V; Karaulov, Alexander V; Lysenko, Maryana A; Logunov, Denis Y; Gintsburg, Alexander L.
Afiliación
  • Fomina DS; Department of Allergy and Immunology, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Lebedkina MS; Allergy and Immunology Department, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
  • Iliukhina AA; Department of Allergy and Immunology, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Kovyrshina AV; State Virus Collection Laboratory, Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Shelkov AY; State Virus Collection Laboratory, Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Andreev SS; State Virus Collection Laboratory, Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Chernov AA; Department of Allergy and Immunology, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Dolzhikova IV; Department of Allergy and Immunology, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Kruglova TS; State Virus Collection Laboratory, Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Andrenova GV; Department of Allergy and Immunology, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Tukhvatulin AI; Department of Allergy and Immunology, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Shcheblyakov DV; State Virus Collection Laboratory, Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Karaulov AV; State Virus Collection Laboratory, Federal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Lysenko MA; Allergy and Immunology Department, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
  • Logunov DY; Department of Allergy and Immunology, City Clinical Hospital No.52 of Moscow Healthcare Department, Moscow, Russia.
  • Gintsburg AL; General Therapy Department, Pirogov Russian National Research Medical University, Moscow, Russia.
Front Immunol ; 14: 1259725, 2023.
Article en En | MEDLINE | ID: mdl-37928549
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Rusia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Tratamiento Farmacológico de COVID-19 Límite: Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Rusia